NCT00614510View on ClinicalTrials.gov

SynCardia CardioWest TAH-t Postmarket Surveillance Study

CompletedOBSERVATIONAL

Enrollment

196

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Biventricular Failure

Interventions

DEVICE

CardioWest temporary Total Artificial Heart (TAH-t)

The SynCardia CardioWest temporary Total Artificial Heart (TAH-t) system is a pulsatile biventricular device that replaces a patient's native ventricles and valves and pumps blood to both the pulmonary and systemic circulation. The system consists of the implantable CardioWest TAH-t and an external console connected by drivelines.

All Listed Sponsors

lead

SynCardia Systems. LLC

INDUSTRY

NCT00614510 - SynCardia CardioWest TAH-t Postmarket Surveillance Study | Biotech Hunter | Biotech Hunter